Agilent Technologies, Inc. (A) revenue by segment
ANYSELaboratory Analytical InstrumentsFiscal year ends October 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 1, 2026Score 21/3019% above fair value
$177.33+5.11 (+2.97%)
Close on Nov 18, 2026Market cap $49.99BP/E 35.0Yield 0.56%
Doanh thu theo bộ phận của Agilent Technologies, Inc.
Periods
Theo bộ phận kinh doanh
| Doanh thu | FY2025CY2025 | FY2024CY2024 | FY2023CY2023 | FY2022CY2022 | FY2021CY2021 | FY2020CY2020 | FY2019CY2019 | FY2018CY2018 | FY2017CY2017 | FY2016CY2016 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent CrossLab | $2.91B | $2.75B | $2.66B | $1.45B | $1.36B | $1.18B | $1.84B | $1.70B | $1.53B | $1.42B | 41.9% | +5.9% |
| Life Sciences and Diagnostics Markets | $2.73B | $2.47B | $2.78B | – | – | – | – | – | – | – | 39.2% | +10.5% |
| Applied Markets | $1.31B | $1.30B | $1.40B | – | – | – | – | – | – | – | 18.9% | +1.3% |
| Diagnostics and Genomics | – | $1.65B | $1.76B | $1.77B | $1.30B | $1.05B | $1.02B | $943.00M | $860.00M | $790.00M | – | – |
| Life Sciences and Applied Markets | – | $3.22B | $3.51B | $3.63B | $3.66B | $3.12B | $2.30B | $2.27B | $2.08B | $1.99B | – | – |
| Segment Total | – | – | – | $6.85B | $6.32B | $5.34B | $5.16B | $4.91B | $4.47B | $4.20B | – | – |
| Lợi nhuận hoạt động | FY2025CY2025 | FY2024CY2024 | FY2023CY2023 | FY2022CY2022 | FY2021CY2021 | FY2020CY2020 | FY2019CY2019 | FY2018CY2018 | FY2017CY2017 | FY2016CY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent CrossLab | $946.00M | $925.00M | $839.00M | $370.00M | $323.00M | $272.00M | $475.00M | $388.00M | $336.00M | $316.00M | +2.3% |
| Life Sciences and Diagnostics Markets | $536.00M | $484.00M | $673.00M | – | – | – | – | – | – | – | +10.7% |
| Applied Markets | $301.00M | $312.00M | $363.00M | – | – | – | – | – | – | – | -3.5% |
| Diagnostics and Genomics | – | $320.00M | $363.00M | $390.00M | $273.00M | $192.00M | $185.00M | $173.00M | $167.00M | $131.00M | – |
| Life Sciences and Applied Markets | – | $877.00M | $1.05B | $1.10B | $1.02B | $792.00M | $542.00M | $543.00M | $470.00M | $412.00M | – |
| Segment Total | – | – | – | $1.86B | $1.61B | $1.26B | $1.20B | $1.10B | $973.00M | $859.00M | – |
Theo sản phẩm hoặc dịch vụ
| Doanh thu | FY2025CY2025 | FY2024CY2024 | FY2023CY2023 | FY2022CY2022 | FY2021CY2021 | FY2020CY2020 | FY2019CY2019 | FY2018CY2018 | FY2017CY2017 | FY2016CY2016 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product | $4.94B | $4.67B | $5.05B | $5.19B | $4.76B | $3.99B | $3.88B | $3.75B | $3.40B | $3.21B | 71.2% | +5.8% |
| Non-Instrumentation and Other | $4.52B | $4.16B | $4.09B | $3.94B | $3.66B | $3.09B | $3.01B | – | – | – | 65.1% | +8.8% |
| Instrumentation | $2.43B | $2.35B | $2.74B | $2.91B | $2.66B | $2.25B | $2.15B | $2.03B | $1.86B | $1.79B | 34.9% | +3.1% |
| Services and Other | $2.00B | $1.84B | $1.78B | $1.66B | $1.56B | $1.35B | $1.29B | $1.17B | $1.08B | $989.00M | 28.8% | +9.0% |
| Analytical lab consumables | – | – | – | – | – | – | – | $618.00M | $540.00M | $510.00M | – | – |
| Informatics and other | – | – | – | – | – | – | – | $238.00M | $223.00M | $202.00M | – | – |
| Analytical Lab Services | – | – | – | – | – | – | – | $1.08B | $991.00M | $910.00M | – | – |
| Diagnostics and genomics solutions | – | – | – | – | – | – | – | $943.00M | $860.00M | $790.00M | – | – |
Theo khu vực
| Doanh thu | FY2025CY2025 | FY2024CY2024 | FY2023CY2023 | FY2022CY2022 | FY2021CY2021 | FY2020CY2020 | FY2019CY2019 | FY2018CY2018 | FY2017CY2017 | FY2016CY2016 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rest Of World | $3.38B | $3.05B | $3.04B | $2.96B | $2.89B | $2.50B | $2.53B | $2.49B | $2.26B | $2.11B | 48.7% | +11.0% |
| Americas | $2.81B | $2.57B | $2.73B | $2.68B | $2.40B | $1.97B | $1.86B | – | – | – | 40.4% | +9.1% |
| United States | $2.34B | $2.25B | $2.41B | $2.39B | $2.16B | $1.75B | $1.62B | $1.41B | $1.31B | $1.25B | 33.7% | +4.3% |
| Asia Pacific | $2.22B | $2.17B | $2.35B | $2.47B | $2.23B | $1.93B | $1.86B | – | – | – | 31.9% | +2.4% |
| Europe | $1.92B | $1.77B | $1.75B | $1.70B | $1.69B | $1.44B | $1.44B | – | – | – | 27.7% | +8.6% |
| China | $1.22B | $1.22B | $1.38B | $1.50B | $1.27B | $1.09B | $1.02B | $1.02B | $900.00M | $839.00M | 17.6% | +0.6% |
Lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K, 10-Q của Agilent Technologies (XBRL). Số quý 4 bằng cả năm tài chính trừ chín tháng đầu. Tên bộ phận giữ theo cách công ty tự đặt và có thể đổi khi công ty tái cấu trúc. Tab KPI hiện các bộ phận này cạnh chỉ số vận hành của Agilent Technologies, kèm đầy đủ lịch sử, biểu đồ và liên kết tới từng hồ sơ.
Chỉ số vận hành
| Remaining performance obligations (RPO) | FY2025CY2025 | FY2024CY2024 | FY2023CY2023 | FY2022CY2022 | FY2021CY2021 | FY2020CY2020 | FY2019CY2019 | YoY |
|---|---|---|---|---|---|---|---|---|
| Remaining performance obligations (RPO) | $437.00M | $409.00M | $331.00M | $357.00M | $299.00M | $217.00M | $207.00M | +6.8% |
Các số lượng và quy mô Agilent Technologies gắn thẻ trong thuyết minh hồ sơ 10-K, 10-Q (XBRL), tính đến cuối mỗi kỳ. Phần phân tách giữ theo cách công ty tự đặt tên; mỗi chỉ số hiện tối đa 15 dòng.
See a number that looks wrong?